| |
Pub Talk
"Data
Integration: The Gateway to Life Science Data
and 'In-Silico' Drug Discovery"
THURSDAY, APRIL 25, 2002
By Mr. Jeff
Edwards
President & Chief Operating Officer
geneticXchange
Open to the Public. No fee. 5:00 - 7:00 p.m.
The Pub Talk begins at 6:00 p.m.
The bottleneck
in drug discovery has shifted from data collection to data integration
and analysis. In fact, poor data integration is seen as a key factor
reducing R&D productivity. Trying to solve the life science
data integration problem using traditional IT approaches is like
trying to fit a square peg into a round hole -- it doesn’t
work. At this Pub, come learn how geneticXchange's K1 System is
providing a revolutionary way to solve this problem, enabling rapid
access to - and integration of - complex, dispersed scientific data.
The business results are accelerated time to market, reduced risk,
and elimination of a long-standing barrier to the drug discovery
process for biotech and pharmaceutical companies.
ABOUT
JEFF EDWARDS
Jeff Edwards is President and Chief Operating Officer of
geneticXchange, the leading provider of data integration solutions
for the biotech industry. Mr. Edwards has over 20 years of experience
in operations, sales, and marketing in the high-tech industry. He
began his career at IBM and has held executive positions with StorageTek
and with Hitachi Data Systems, where he built a $100 million business
unit as Vice President/General Manager. In addition, executives
from Fortune 500 companies such as Computer Associates and AT&T
have engaged Mr. Edwards to design various IT-based business models.
He holds a BA in business administration with graduate studies at
Northwestern University's J.L. Kellogg Graduate School of Management
in international marketing.
ABOUT
GENETICXCHANGE
Headquartered in Menlo Park, California, geneticXchange
(http://www.geneticXchange.com)
provides the only open system data integration platform to help
accelerate the drug discovery process. geneticXchange's powerful
K1 System software product provides rapid, real-time access to,
and integration of, complex dispersed scientific data. World leaders
such as the Genome Institute of Singapore and Genomics Collaborative,
Inc. leverage the K1 System to help realize the promise of 'in-silico'
drug discovery.
For
Further Information & a Copy of the PowerPoint Presentation,
Contact:
Ms. Melanie Flanigan
Vice President, Marketing
geneticXchange
T: 650.321.9573 ext. 407
E: mailto:mflanigan@geneticxchange.com
|
